MICROPORT CARDIO.MEDTECH. (72X) — Working Capital to Net Assets Ratio
MICROPORT CARDIO.MEDTECH. (72X) has a Working Capital to Net Assets ratio of 65.8% as of June 2025. Working capital of €1.46 Billion (current assets of €1.70 Billion minus current liabilities of €245.53 Million) is measured against net assets of €2.22 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See MICROPORT CARDIO.MEDTECH. (72X) defensive interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
MICROPORT CARDIO.MEDTECH. Working Capital to Net Assets (2021–2024)
This chart shows how MICROPORT CARDIO.MEDTECH.'s Working Capital to Net Assets ratio has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the ratio stands at 65.8%, reflecting working capital of €1.46 Billion against net assets of €2.22 Billion EUR. For the complete balance sheet picture, see MICROPORT CARDIO.MEDTECH. balance sheet assets.
Annual Working Capital to Net Assets for MICROPORT CARDIO.MEDTECH. (2021–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for MICROPORT CARDIO.MEDTECH. from 2021 to 2024, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check MICROPORT CARDIO.MEDTECH. liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 55.8% | €1.24 Billion | €2.22 Billion | €1.67 Billion | €433.89 Million | ▼ -23.3 pp |
| 2023 | 79.1% | €1.85 Billion | €2.33 Billion | €2.04 Billion | €193.58 Million | ▲ +3.1 pp |
| 2022 | 76.1% | €2.09 Billion | €2.75 Billion | €2.27 Billion | €177.23 Million | ▼ -2.6 pp |
| 2021 | 78.6% | €2.44 Billion | €3.10 Billion | €2.60 Billion | €164.43 Million | — |